RespiratoryCHONLUTEN
30MG
$75
Description
Chonluten is a bioregulatory tripeptide (Glu-Asp-Gly) developed by Professor Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology. It is part of the Khavinson peptide family of short bioregulators that target specific organ systems through epigenetic mechanisms. Chonluten specifically targets bronchial and lung tissue, promoting the normalization of respiratory function and supporting the regeneration of bronchial mucosal lining. It works by interacting with DNA to regulate gene expression related to respiratory tissue maintenance, repair, and mucosal immunity. This makes it a valuable research compound for studying respiratory health, lung tissue aging, and bronchial regeneration.
Potential Benefits
Research Notes
Chonluten was developed as part of the Khavinson bioregulation program, which has produced organ-specific short peptides through decades of research at the Saint Petersburg Institute. Published studies in the Bulletin of Experimental Biology and Medicine demonstrate that Chonluten normalizes respiratory function markers and promotes bronchial tissue regeneration in aging and damage models. Research shows these short bioregulatory peptides can penetrate cell nuclei and interact with specific DNA sequences to modulate gene expression. CAS number: 75007-24-8.
Usage Information
For research and educational purposes only. Consult with a qualified professional before use.
All peptides must be refrigerated upon receipt.
RESEARCH PURPOSES ONLY
This product is intended for research and educational purposes only. Not intended for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.